PP-368 Management of HeartWare Left Ventricular Assist Device Thrombosis Using Intracavitary Thrombolytics

Left ventricular assist devices (LVAD) are increasingly being used to bridge patients to cardiac transplantation and as permanent therapy for selected patients with endstage heart failure. Conclusions LVAD thrombosis is a potentially life-threatening complication requiring prompt diagnosis and manag...

Full description

Saved in:
Bibliographic Details
Published inThe American journal of cardiology Vol. 113; no. 7; p. S156
Main Authors Tuncer, O.N, Kemaloğlu, C, Erbasan, O, Türkay, C, Bayezid, Ö
Format Journal Article
LanguageEnglish
Published New York Elsevier Inc 01.04.2014
Elsevier Limited
Subjects
Blood pressure
Cardiovascular
Catheters
Heart failure
Thrombosis
Online AccessGet full text

Cover

More Information
Summary:Left ventricular assist devices (LVAD) are increasingly being used to bridge patients to cardiac transplantation and as permanent therapy for selected patients with endstage heart failure. Conclusions LVAD thrombosis is a potentially life-threatening complication requiring prompt diagnosis and management As nonpulsatile LVADs are increasingly applied in the management of end-stage heart failure, standardization of the percutaneous management of device thrombosis may be necessary.
ISSN:0002-9149
1879-1913
DOI:10.1016/j.amjcard.2014.01.399